2022
DOI: 10.3390/healthcare10112211
|View full text |Cite
|
Sign up to set email alerts
|

Quality of Life and Depressive Symptoms in Transcatheter Aortic Valve Implementation Patients—A Cross-Sectional Study

Abstract: Quality of life is an important factor influencing mood. In any group of elderly people undergoing valve implementation or surgical aortic valve replacement, one in three will have depressive symptoms. The aims of this study were as follows: 1. to evaluate the impact of health-related quality of life on depressive symptoms in elderly patients undergoing TAVI, and 2. to analyze beliefs about TAVI. Methods: A total of 131 elderly people (mean age: 82.1 ± 6.1 years) scheduled to receive TAVI completed the Geriatr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…42 At the same time in the population, the prevalence of major depression in Europe is estimated at 6.6-6-9% while in the USA in adults >65 years of age it is 9.1%, while in the population with coronary heart disease it is 15-30%, which means that one in three older patients who undergo surgical or percutaneous valve surgery have prolonged depressive symptoms that prevent them from getting an adequate improvement, increased adverse effects and consequently lower quality life. 43 On the other hand, patients are more likely to adopt unhealthy behaviors such as smoking, physical inactivity, poor nutrition and less adherence to treatment. To mention congenital heart disease, it is estimated that between 17% and 27% suffer from major depression related to New York Heart Association (NYHA) class IV classification together with a 3-fold higher mortality rate.…”
Section: Epidemiology Of Anxiety and Depressionmentioning
confidence: 99%
“…42 At the same time in the population, the prevalence of major depression in Europe is estimated at 6.6-6-9% while in the USA in adults >65 years of age it is 9.1%, while in the population with coronary heart disease it is 15-30%, which means that one in three older patients who undergo surgical or percutaneous valve surgery have prolonged depressive symptoms that prevent them from getting an adequate improvement, increased adverse effects and consequently lower quality life. 43 On the other hand, patients are more likely to adopt unhealthy behaviors such as smoking, physical inactivity, poor nutrition and less adherence to treatment. To mention congenital heart disease, it is estimated that between 17% and 27% suffer from major depression related to New York Heart Association (NYHA) class IV classification together with a 3-fold higher mortality rate.…”
Section: Epidemiology Of Anxiety and Depressionmentioning
confidence: 99%